Thyroid Eye Disease

Also known as: Thyroid-Related Eye Disease / Graves' Ophthalmopathy (GO) / Thyroid Related Eye Disease / Graves ophthalmopathy / Graves eye disease (disorder) / Thyroid eye disease with exophthalmos (disorder) / Endocrine exophthalmos (disorder) / Thyroid eye disease (disorder) / Thyroid orbitopathy (disorder) / Dysthyroid ophthalmopathy / Graves' ophthalmopathy / Endocrine ophthalmopathy / Endocrine exophthalmos / Endocrine exophthalmos NOS (disorder) / Exophthalmos endocrine

DrugDrug NameDrug Description
DB00635PrednisoneA corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases.
DB06343TeprotumumabA fully human monoclonal antibody directed against insulin-like growth factor-1 receptor for the treatment of thyroid eye disease.
DrugDrug NamePhaseStatusCount
DB00905Bimatoprost0Recruiting1
DB00207Azithromycin1 / 2Withdrawn1
DB00254Doxycycline1 / 2Completed1
DB08885Aflibercept2Not Yet Recruiting1
DB00482Celecoxib2Terminated1
DB00254Doxycycline2Unknown Status1
DB00959Methylprednisolone2Terminated1
DB05496Otelixizumab2Terminated1
DB00959Methylprednisolone2 / 3Not Yet Recruiting1
DB09100Thyroid, porcine2 / 3Recruiting1
DB00763Methimazole3Unknown Status1
DB00550Propylthiouracil3Unknown Status1
DB00641Simvastatin3Recruiting1
DB09153Sodium chloride3Completed1
DB06343Teprotumumab3Active Not Recruiting2
DB06273Tocilizumab3Completed1
DB00905Bimatoprost4Withdrawn1
DB00083Botulinum toxin type A4Withdrawn1
DB08818Hyaluronic acid4Recruiting1
DB00654Latanoprost4Withdrawn1
DB00959Methylprednisolone4Unknown Status1
DB09153Sodium chloride4Not Yet Recruiting1
DB08819Tafluprost4Withdrawn1
DB06343Teprotumumab4Not Yet Recruiting1
DB00373Timolol4Withdrawn1
DB00287Travoprost4Withdrawn1
DB01200BromocriptineNot AvailableTerminated1
DB00763MethimazoleNot AvailableTerminated1
DB00959MethylprednisoloneNot AvailableCompleted3
DB00959MethylprednisoloneNot AvailableRecruiting1
DB00806PentoxifyllineNot AvailableTerminated1
DB00706TamsulosinNot AvailableNot Yet Recruiting1
DB06343TeprotumumabNot AvailableApproved for Marketing1